Adult; Cells, Cultured; Drug Users; HIV Infections/immunology/virology; HIV-1/immunology; Humans; Substance Abuse, Intravenous/complications; T-Lymphocytes/immunology
Abstract :
[en] Abstract We previously observed limited cross-reactive T cell responses in two HIV-1-superinfected injection drug users (IDUs) before superinfection [Ramos A, et al.: J Virol 2002;76(15):7444-7452]. To elucidate the role of such responses in superinfection we examined cross-reactive T cell responses in IDUs infected with a single HIV-1 subtype. In this study, IFN-gamma ELISPOT assays were performed using recombinant vaccinia constructs and peripheral blood mononuclear cells (PBMCs) from 43 IDUs singly infected with CRF01_AE or B' from the same cohort as the superinfected IDUs. PBMCs were from time points corresponding to pre- (early) or post- (late) superinfection in the superinfected IDUs. We observed that most singly infected IDUs had cross-reactivity in samples from early (84% of CRF01_AE and 78% of B'-infected IDUs) and late (96% of CRF_01AE and 77% of B'-infected IDUs) time points. Frequent homologous reactivity at early (67% of CRF-01AE and 100% of B') and late (84% of CRF01_AE-infected and 100% of B'-infected IDUs) time points was also observed. Cross-reactive responses were predominantly to Pol and were broader and higher in CRF01_AE than in B'-infected IDUs (medians of 825 vs. 90 and 585 vs. 60 spot-forming units/10(6) PBMCs at early and late time points, respectively). Our results show that cross-reactive responses were more prevalent with greater height and breadth in singly infected IDUs than previously observed in corresponding collection time points of superinfected IDU. Thus, low or absent cross-reactivity may have contributed to the previously observed superinfections. These data are relevant for understanding superinfection and improving vaccine design.
Disciplines :
Immunology & infectious disease
Author, co-author :
Promadej-Lanier, Nattawan
Thielen, Caroline ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Hu, Dale J
Chaowanachan, Thanyanan
Gvetadze, Roman
Choopanya, Kachit
Vanichseni, Suphak
McNicholl, Janet M
Language :
English
Title :
Cross-reactive T cell responses in HIV CRF01_AE and B'-infected intravenous drug users: implications for superinfection and vaccines.
Publication date :
2009
Journal title :
AIDS Research and Human Retroviruses
ISSN :
0889-2229
eISSN :
1931-8405
Publisher :
Mary Ann Liebert, Inc., Larchmont, United States - New York
Ramos A., Hu D.J., Nguyen L., et al.: Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 2002;76(15):7444–7452.
Ou C.Y., Takebe Y., Luo C.C., et al.: Wide distribution of two subtypes of HIV-1 in Thailand. AIDS Res Hum Retroviruses 1992;8(8):1471–1472.
Vanichseni S., Kitayaporn D., Mastro T.D., et al.: Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS 2001; 15(3):397–405.
Weniger B.G., Limpakarnjanarat K., Ungchusak K., et al.: The epidemiology of HIV infection and AIDS in Thailand. AIDS 1991;5(Suppl. 2):S71–85.
Hu D.J., Vanichseni S., Mastro T.D., et al.: Viral load differences in early infection with two HIV-1 subtypes. AIDS 2001;15(6): 683–691.
Buchacz K., Hu D.J., Vanichseni S., et al.: Early markers of HIV-1 disease progression in a prospective cohort of seroconverters in Bangkok, Thailand: Implications for vaccine trials. J Acquir Immune Defic Syndr 2004;36(3):853–860.
Pau C.P., Lee-Thomas S., Auwanit W., et al.: Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand. AIDS 1993;7(3):337–340.
Subbarao S., Vanichseni S., Hu D.J., et al.; Genetic characterization of incident HIV type 1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand. AIDS Res Hum Retroviruses 2000;16(8):699–707.
Kitayaporn D., Vanichseni S., Mastro T.D., et al.: Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19(3): 289–295.
Nguyen L., Chaowanachan T., Vanichseni S., et al.: Frequent human leukocyte antigen class I alleles are associated with higher viral load among HIV type 1 seroconverters in Thailand. J Acquir Immune Defic Syndr 2004;37(2):1318–1323.
Promadej N., Costello C., Wernett M.M., et al.: Broad human immunodeficiency virus (HIV)-specific T cell responses to conserved HIV proteins in HIV-seronegative women highly exposed to a single HIV-infected partner. J Infect Dis 2003; 187(7):1053–1063.
Barugahare B., Baker C., K'Aluoch O., et al.: Human immunodeficiency virus-specific responses in adult Ugandans: Patterns of cross-clade recognition. J Virol 2005;79(7):4132- 4139.
Betts M.R., Krowka J., Santamaria C., et al.: Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J Virol 1997;71(11):8908–8911.
Cao H., Kanki P., Sankale J.L., et al.: Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development. J Virol 1997;71(11):8615–8623.
Cao H., Mani I., Vincent R., et al.: Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: Relevance to HIV-1 vaccine trials in Uganda. J Infect Dis 2000;182(5): 1350–1356.
Coplan P.M., Gupta S.B., Dubey S.A., et al.: Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J Infect Dis 2005;191(9):1427–1434.
Currier J.R., Dowling W.E., Wasunna K.M., Alam U., et al.: Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans. AIDS 2003;17(15):2149–2157.
Currier J.R., deSouza M., Chanbancherd P., et al.: Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles. J Virol 2002;76(10):4971–4986.
Durali D., Morvan J., Letourneur F., et al.: Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients. J Virol 1998;72(5):3547–3553.
Gupta S.B., Mast C.T., Wolfe N.D., et al.: Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon. J Acquir Immune Defic Syndr 2006;42(2):135–139.
Inwoley A., Recordon-Pinson P., Dupuis M., et al.: Cross-clade conservation of HIV type 1 Nef immunodominant regions recognized by CD8+T cells of HIV type 1 CRF02_AG-infected Ivorian (West Africa). AIDS Res Hum Retroviruses 2005;21(7):620–628.
Keating S.M., Bollinger R.C., Quinn T.C., Jackson J.B., and Carruth L.M.: Cross-clade T lymphocyte-mediated immunity to HIV type 1: Implications for vaccine design and immuno-detection assays. AIDS Res Hum Retroviruses 2002;18(14): 1067–1079.
Lynch J.A., deSouza M., Robb M.D., et al.: Cross-clade cytotoxic T cell response to human immunodeficiency virus type 1 proteins among HLA disparate North Americans and Thais. J Infect Dis 1998;178(4):1040–1046.
Malhotra U., Nolin J., Mullins J.I., and McElrath M.J.: Comprehensive epitope analysis of cross-clade Gag-specific T-cell responses in individuals with early HIV-1 infection in the US epidemic. Vaccine 2007;25(2):381–390.
McAdam S., Kaleebu P., Krausa P., et al.: Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection. AIDS 1998;12(6):571–579.
McKinnon L.R., Ball T.B., Kimani J., et al.: Cross-clade CD8(+) T-cell responses with a preference for the predominant circulating clade. J Acquir Immune Defic Syndr 2005;40(3): 245–249.
Yu X.G., Lichterfeld M., Perkins B., et al.: High degree of inter-clade cross-reactivity of HIV-1-specific T cell responses at the single peptide level. AIDS 2005;19(14):1449–1456.
Zhao S., Zhai S., Zhuang Y., et al.: Inter-clade cross-reactivity of HIV-1-specific T cell responses in human immunodeficiency virus type 1 infection in China. Curr HIV Res 2007;5(2):251–259.
Hu D.J., Subbarao S., Vanichseni S., et al.: Frequency of HIV-1 dual subtype infections, including intersubtype superinfections, among injection drug users in Bangkok, Thailand. AIDS 2005;19(3):303–308.
Edwards B.H., Bansal A., Sabbaj S., et al.: Magnitude of functional CD8+T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol 2002;76(5):2298–2305.
Greenough T.C., Brettler D.B., Somasundaran M., Panicali D.L., and Sullivan J.L.: Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: Evidence supporting a protective role for CTL in vivo. J Infect Dis 1997;176(1):118–125.
Kaech S.M. and Ahmed R.: Memory CD8+T cell differentiation: Initial antigen encounter triggers a developmental program in naive cells. [See comments.] Nat Immunol 2001; 2(5):415–422.
Ludewig B., Oehen S., Barchiesi F., et al.: Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells. J Immunol 1999;163(4): 1839–1844.
Zinkernagel R.M. and Hengartner H.: Regulation of the immune response by antigen. Science 2001;293(5528):251–253.
